spacer
spacer

PDBsum entry 4qa6

Go to PDB code: 
protein ligands metals Protein-protein interface(s) links
Hydrolase PDB id
4qa6

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
364 a.a.
Ligands
ACE-ARG-HIS-ALY-
ALY
×2
GOL ×2
MCM ×2
Metals
__K ×4
_ZN ×2
Waters ×385
PDB id:
4qa6
Name: Hydrolase
Title: Crystal structure of i243n/y306f hdac8 in complex with a tetrapeptide substrate
Structure: Histone deacetylase 8. Chain: a, b. Synonym: hd8. Engineered: yes. Mutation: yes. Tetrapeptide substrate. Chain: c, d. Engineered: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Gene: hdac8, hdacl1, cda07. Expressed in: escherichia coli. Expression_system_taxid: 469008. Synthetic: yes. Other_details: synthetic peptide
Resolution:
2.05Å     R-factor:   0.182     R-free:   0.212
Authors: C.Decroos,C.B.Bowman,J.-A.S.Moser,K.E.Christianson,M.A.Deardorff, D.W.Christianson
Key ref: C.Decroos et al. (2014). Compromised structure and function of HDAC8 mutants identified in Cornelia de Lange Syndrome spectrum disorders. Acs Chem Biol, 9, 2157-2164. PubMed id: 25075551 DOI: 10.1021/cb5003762
Date:
02-May-14     Release date:   06-Aug-14    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
Q9BY41  (HDAC8_HUMAN) -  Histone deacetylase 8 from Homo sapiens
Seq:
Struc:
377 a.a.
364 a.a.*
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 2 residue positions (black crosses)

 Enzyme reactions 
   Enzyme class: E.C.3.5.1.98  - histone deacetylase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: N6-acetyl-L-lysyl-[histone] + H2O = L-lysyl-[histone] + acetate
N(6)-acetyl-L-lysyl-[histone]
+ H2O
= L-lysyl-[histone]
Bound ligand (Het Group name = ACE)
matches with 75.00% similarity
+ acetate
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    Key reference    
 
 
DOI no: 10.1021/cb5003762 Acs Chem Biol 9:2157-2164 (2014)
PubMed id: 25075551  
 
 
Compromised structure and function of HDAC8 mutants identified in Cornelia de Lange Syndrome spectrum disorders.
C.Decroos, C.M.Bowman, J.A.Moser, K.E.Christianson, M.A.Deardorff, D.W.Christianson.
 
  ABSTRACT  
 
Cornelia de Lange Syndrome (CdLS) is a multiple congenital anomaly disorder resulting from mutations in genes that encode the core components of the cohesin complex, SMC1A, SMC3, and RAD21, or two of its regulatory proteins, NIPBL and HDAC8. HDAC8 is the human SMC3 lysine deacetylase required for cohesin recycling in the cell cycle. To date, 16 different missense mutations in HDAC8 have recently been identified in children diagnosed with CdLS. To understand the molecular effects of these mutations in causing CdLS and overlapping phenotypes, we have fully characterized the structure and function of five HDAC8 mutants: C153F, A188T, I243N, T311M, and H334R. X-ray crystal structures reveal that each mutation causes local structural changes that compromise catalysis and/or thermostability. For example, the C153F mutation triggers conformational changes that block acetate product release channels, resulting in only 2% residual catalytic activity. In contrast, the H334R mutation causes structural changes in a polypeptide loop distant from the active site and results in 91% residual activity, but the thermostability of this mutant is significantly compromised. Strikingly, the catalytic activity of these mutants can be partially or fully rescued in vitro by the HDAC8 activator N-(phenylcarbamothioyl)benzamide. These results suggest that HDAC8 activators might be useful leads in the search for new therapeutic strategies in managing CdLS.
 

 

spacer

spacer